SAKAR HEALTHCARE Financial Statement Analysis
|
||
|
The Revenues of SAKAR HEALTHCARE have increased by 14.99% YoY .
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has increased by 48.42 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SAKAR HEALTHCARE Last 5 Annual Financial Results
[NSE : SAKAR]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹153 Cr | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr |
| Expenses | ₹115 Cr | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr |
| Operating Profit (Excl OI) | ₹38 Cr | ₹33 Cr | ₹29 Cr | ₹23 Cr | ₹1,954,905 Cr |
| Other Income | ₹3.18 Cr | ₹4.68 Cr | ₹2.17 Cr | ₹1.18 Cr | ₹201,684 Cr |
| Interest | ₹7.62 Cr | ₹5.96 Cr | ₹2.91 Cr | ₹2.50 Cr | ₹225,918 Cr |
| Depreciation | ₹18 Cr | ₹15 Cr | ₹9.67 Cr | ₹8.06 Cr | ₹707,981 Cr |
| Profit Before Tax | ₹16 Cr | ₹17 Cr | ₹19 Cr | ₹13 Cr | ₹1,222,691 Cr |
| Profit After Tax | ₹12 Cr | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr |
| Consolidated Net Profit | ₹12 Cr | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr |
| Earnings Per Share (Rs) | ₹7.97 | ₹5.37 | ₹6.70 | ₹8.87 | ₹6.84 |
| PAT Margin (%) | 9.86 | 7.61 | 9.57 | 11.84 | 11.28 |
| ROE(%) | 6.48 | 5.42 | 8.48 | 13.44 | 11.88 |
| ROCE(%) | 8.43 | 7.42 | 8.95 | 12.09 | 13.16 |
| Total Debt/Equity(x) | 0.31 | 0.31 | 0.69 | 0.73 | 0.43 |
Key Financials |
||
| Market Cap | : | ₹ 899.9 Cr |
| Revenue (TTM) | : | ₹ 204.0 Cr |
| Net Profit(TTM) | : | ₹ 19.5 Cr |
| EPS (TTM) | : | ₹ 8.8 |
| P/E (TTM) | : | 46.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SAKAR HEALTHCARE | 6.6% | -2.3% | 38.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -3.5% | -6.4% | -2.6% |
| DIVIS LABORATORIES | -5.8% | -1.6% | 10.9% |
| CIPLA | -4.7% | -6.8% | -0.3% |
| TORRENT PHARMACEUTICALS | 1.4% | 7% | 23.7% |
| DR REDDYS LABORATORIES | -2.8% | -8.1% | -11.1% |
| MANKIND PHARMA | -1.1% | 3.3% | -13.4% |
| ZYDUS LIFESCIENCES | -3% | -5% | -9.3% |
| LUPIN | -0.2% | 4.1% | 1.9% |
SAKAR HEALTHCARE Revenues
[NSE : SAKAR]
| Y-o-Y | 14.99 % |
| 5 Yr CAGR | -93.44 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 14.99 | |
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | - | |
SAKAR HEALTHCARE Operating Profit
[NSE : SAKAR]
| Y-o-Y | 15.40 % |
| 5 Yr CAGR | -93.34 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | 15.40 | |
| Mar2024 | ₹33 Cr | 13.39 | |
| Mar2023 | ₹29 Cr | 29.75 | |
| Mar2022 | ₹23 Cr | -100.00 | |
| Mar2021 | ₹1,954,905 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 0.36 % |
| 5 Yr CAGR | 1.52 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 25.03% | 0.36 | |
| Mar2024 | 24.94% | 9.00 | |
| Mar2023 | 22.88% | -4.15 | |
| Mar2022 | 23.87% | 1.32 | |
| Mar2021 | 23.56% | - | |
SAKAR HEALTHCARE Profit After Tax
[NSE : SAKAR]
| Y-o-Y | -8.53 % |
| 5 Yr CAGR | -94.10 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | -8.53 | |
| Mar2024 | ₹13 Cr | -15.95 | |
| Mar2023 | ₹15 Cr | 42.09 | |
| Mar2022 | ₹11 Cr | -100.00 | |
| Mar2021 | ₹962,285 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 29.57 % |
| 5 Yr CAGR | -3.31 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 9.86 % | 29.57 | |
| Mar2024 | 7.61 % | -20.48 | |
| Mar2023 | 9.57 % | -19.17 | |
| Mar2022 | 11.84 % | 4.96 | |
| Mar2021 | 11.28 % | - | |
SAKAR HEALTHCARE Earnings Per Share (EPS)
[NSE : SAKAR]
| Y-o-Y | 48.42 % |
| 5 Yr CAGR | 3.90 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.97 | 48.42 | |
| Mar2024 | ₹5.37 | -19.85 | |
| Mar2023 | ₹6.70 | -24.46 | |
| Mar2022 | ₹8.87 | 29.68 | |
| Mar2021 | ₹6.84 | - | |
SAKAR HEALTHCARE Return on Capital Employed (ROCE)
[NSE : SAKAR]
| Y-o-Y | 13.61 % |
| 5 Yr CAGR | -10.54 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 8.43% | 13.61 | |
| Mar2024 | 7.42% | -17.09 | |
| Mar2023 | 8.95% | -25.97 | |
| Mar2022 | 12.09% | -8.13 | |
| Mar2021 | 13.16% | - | |
SAKAR HEALTHCARE Share Price vs Sensex
| Current Share Price | : | ₹405.4 |
| Current MarketCap | : | ₹ 899.9 Cr |
| Updated EOD on | : | Jan 16,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 6.6% |
-2.3% |
38.9% |
| SENSEX | -0.7% |
-1.9% |
8% |
SAKAR HEALTHCARE related INDICES
You may also like the below Video Courses
FAQ about SAKAR HEALTHCARE Financials
How the annual revenues of SAKAR HEALTHCARE have changed ?
The Revenues of SAKAR HEALTHCARE have increased by 14.99% YoY .
How the Earnings per Share (EPS) of SAKAR HEALTHCARE have changed?
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has increased by 48.42 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs